AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Fredriksson, A Danysz, W Quack, G Archer, T
Citation: A. Fredriksson et al., Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice, J NEURAL TR, 108(2), 2001, pp. 167-187

Authors: Kelly, JM Quack, G Miles, MM
Citation: Jm. Kelly et al., In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei, ANTIM AG CH, 45(5), 2001, pp. 1360-1366

Authors: Parsons, CG Danysz, W Quack, G
Citation: Cg. Parsons et al., Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists - in vitro characterisation, AMINO ACIDS, 19(1), 2000, pp. 157-166

Authors: Danysz, W Parsons, CG Quack, G
Citation: W. Danysz et al., NMDA channel blockers: memantine and amino-aklylcyclohexanes - In vivo characterization, AMINO ACIDS, 19(1), 2000, pp. 167-172

Authors: Albrecht, J Hilgier, W Zielinska, M Januszewski, S Hesselink, M Quack, G
Citation: J. Albrecht et al., Extracellular concentrations of taurine, glutamate, and aspartate in the cerebral cortex of rats at the asymptomatic stage of thioacetamide-induced hepatic failure: Modulation by ketamine anesthesia, NEUROCHEM R, 25(11), 2000, pp. 1497-1502

Authors: Jirgensons, A Kauss, V Kalvinsh, I Gold, MR Danysz, W Parsons, CG Quack, G
Citation: A. Jirgensons et al., Synthesis and structure-affinity relationships of 1,3,5-alkylsubstituted cyclohexylamines binding at NMDA receptor PCP site, EUR J MED C, 35(6), 2000, pp. 555-565

Authors: Wenk, GL Quack, G Moebius, HJ Danysz, A
Citation: Gl. Wenk et al., No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use, LIFE SCI, 66(12), 2000, pp. 1079-1083

Authors: Ametamey, SM Samnick, S Leenders, KL Vontobel, P Quack, G Parsons, CG Schubiger, PA
Citation: Sm. Ametamey et al., Fluorine-18 radiolabelling, biodistribution studies and preliminary pet evaluation of a new memantine derivative for imaging the NMDA receptor, J RECEPT SI, 19(1-4), 1999, pp. 129-141

Authors: Rose, C Michalak, A Rao, KVR Quack, G Kircheis, G Butterworth, RF
Citation: C. Rose et al., L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure, HEPATOLOGY, 30(3), 1999, pp. 636-640

Authors: Parsons, CG Danysz, W Quack, G
Citation: Cg. Parsons et al., Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data, NEUROPHARM, 38(6), 1999, pp. 735-767

Authors: Parsons, CG Danysz, W Bartmann, A Spielmanns, P Frankiewicz, T Hesselink, M Eilbacher, B Quack, G
Citation: Cg. Parsons et al., Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonistswith strong voltage-dependency and fast blocking kinetics: in vitro and invivo characterization, NEUROPHARM, 38(1), 1999, pp. 85-108

Authors: Wohlfrom, M Hanke, S Kamenz, J Voisard, R Heise, N Seibold, G Lenz, C Quack, G Wuhlfroth, P Hanke, H
Citation: M. Wohlfrom et al., Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty, CORON ART D, 9(12), 1998, pp. 831-837

Authors: Pugovics, O Kauss, V Kalvinsh, I Gold, MR Quack, G
Citation: O. Pugovics et al., Convenient synthesis of 2,6-di-tert-butyl-4-[5-(3-pyridyl)-4-oxapentyl]phenols and their thia-analogues, J CHEM R-S, (8), 1998, pp. 430-432A

Authors: Quack, G
Citation: G. Quack, Amantadine reduces motor fluctuations induced by L-Dopa - Practical and clinical results, AKT NEUROL, 25, 1998, pp. S258-S260

Authors: Karcz-Kubicha, M Quack, G Danysz, W
Citation: M. Karcz-kubicha et al., Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats, J NEURAL TR, 105(10-12), 1998, pp. 1229-1236
Risultati: 1-15 |